Adrian Charles Curran

This inventor holds 32 USPTO granted patents, primarily in Quinoline Derivatives. Top assignees: John Wyeth Brother, Limited, USA as Represented by Secretary of the Navy. Active years: 1976-1979.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Charles Curran. Retrieved from https://idiyas.com/inventor/adrian-charles-curran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32

% Patents Active = 100.0

Average Co-Inventor Count = 1.4

ph-index = 7

Forward Citations = 242(Granted Patents)

Location History:

Gosforth, EN (1976)
Newcastle-upon-Tyne, EN (1976 - 1977)
Reading, EN (1976 - 1977)
South Cave, EN (1977 - 1978)
North Humberside, EN (1977 - 1978)
Newcastle-upon-Tyne, GB (1979)

Company Filing History:

31 out of 299

John Wyeth Brother, Limited

patents

1 out of 16,283

USA as Represented by Secretary of the Navy

patents

Years Active: 1976-1979

Loading Chart...

Areas of Expertise:

Tetrahydroquinoline Derivatives

Quinoline Derivatives

Piperidine Derivatives

Phenanthridine Derivatives

Pyridine Derivatives

Cyclopenteno[b]pyridine Derivatives

Thiohydantoin Derivatives

Amino Ethanol-Indane Derivatives

Silicon Derivatives

Carboxylic Acid Salts

Grignard Derivatives

Magnesium Halide Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4160094 - Tetrahydroquinoline derivatives (1979-07-03),

2. 4092418 - Certain 1-carbothioamides of 1,5-naphthyridine derivatives (1978-05-30),

3. 4092320 - Certain 1-(N-acyl)-carbothioamides of 1,5-naphthyridine derivatives (1978-05-30),

4. 4092317 - Preparation of quinoline derivatives (1978-05-30),

5. 4085215 - Certain 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides (1978-04-18),

6. 4085110 - 1,2,3,5,6,7-Hexahydrodicyclopenta[b,e]pyridine derivatives (1978-04-18),

7. 4085108 - Silicon derivatives of tetrahydroquinolines (1978-04-18),

8. 4051139 - Pyridine grignard derivatives (1977-09-27),

9. 4048175 - Tetrahydroquinoline derivatives (1977-09-13),

10. 4046895 - Phenanthridine derivatives and related compounds (1977-09-06),

11. 4044138 - Pharmaceutical compositions containing 5,6,7,8-tetrahydroquinoline (1977-08-23),

12. 4031102 - Cyclopenteno[b]pyridine derivatives (1977-06-21),

13. 4029668 - Cyclopenteno[b]pyridine derivatives (1977-06-14),

14. 4029667 - Certain 1-carbothioamides of 1,8-naphthyridines, pyrrolo(2,3-b)pyridines (1977-06-14),

15. 4011331 - Piperidine derivatives (1977-03-08),

Title: Adrian Charles Curran: Innovator in Pharmaceutical Patents

Introduction

Adrian Charles Curran, hailing from South Cave, England, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With 32 patents to his name, Curran has made strides in developing innovative compounds aimed at addressing various medical conditions, particularly in the realm of anti-ulcer treatments.

Latest Patents

Among his latest groundbreaking inventions are the tetrahydroquinoline derivatives, which serve as intermediates useful in the preparation of anti-ulcer agents. These new derivatives contain specific structural components that include sodium, potassium, or lithium, as well as various alkyl and phenyl radicals. Additionally, Curran has patented certain 1-(N-acyl)-carbothioamides derived from 1,5-naphthyridine derivatives. These compounds also serve as intermediates for anti-ulcer agents, showcasing his focus on enhancing therapeutic options in this area.

Career Highlights

Throughout his career, Adrian Curran has worked with reputable organizations such as John Wyeth & Brother Limited and the United States of America, as represented by the Secretary of the Navy. His work within these esteemed companies has enabled him to focus on pharmaceutical innovation, leading to the development of multiple patents that contribute to medical science.

Collaborations

Curran's collaborative efforts have also played a significant role in his success as an inventor. He has had the opportunity to work alongside talented professionals like Roger Crossley and David George Hill. Together, they have advanced the research and development of pharmaceutical compounds, ensuring a significant impact on health care solutions.

Conclusion

Adrian Charles Curran stands out as a prominent figure in the world of pharmaceutical patents. With his innovative approach to developing new medical compounds, he continues to enhance treatment options available for patients. Curran's extensive patent portfolio reflects his commitment to improving health outcomes through scientific discovery and collaboration.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]